SBIR/STTR Research Award
STROKE REHABILITATION DEVICE
Award amount
$50,000Program and phase
SBIR · Phase IAward year
1991Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Axonix Inc
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
WE SEEK TO DEVELOP A VIABLE, COST-EFFECTIVE, SAFE STROKE REHABILITATION DEVICE BASED UPON THE ELECTRONIC STIMULATION OF STROKE-AFFECTED LIMBS. A KEY PROBLEM IN STROKE REHABILITATION THERAPY IS TO HAVE THE STROKE IMPAIRED LIMBS EXERCISED ENOUGH TO AVOID MUSCLE ATROPHY OR DEFORMATION FROM CONTRACTURES. IN GENERAL, PHYSICAL THERAPISTS DO NOT HAVE SUFFICIENT TIME TO WORK WITH THE PATIENT TO PROVIDE THE OPTIMUM RECOVERY RESULT. THE EFFECT OF THIS TO SOCIETY IS 500,000 STROKES PER YEAR WITH $50,000 SPENT ON EACH PATIENT IN AVERAGE STROKE RECOVERY COSTS, LONGRECOVERY TIMES, AND IN MANY CASES, INCOMPLETE RECOVERY. IMPLANTABLE INTELLIGENT ELECTRONIC STIMULATION DEVICES SHOULD SPEED RECOVERY, LOWER PHYSICAL THERAPY COST, AND IMPROVE RECOVERY PROGNOSIS. IN PHASE I, WE WILL EVALUATE THE FEASIBILITY OF DEVELOPING A PRACTICAL DEVICE, WHILE IN PHASE II, WE WOULD BUILD AND TEST A PRE-PRODUCTION PROTOTYPE. THE DEVICE COULD LEAD TO A $250,000,000 MARKET IN SIX YEARS. WE SEEK TO DEVELOP A VIABLE, COST-EFFECTIVE, SAFE STROKE REHABILITATION DEVICE BASED UPON THE ELECTRONIC STIMULATION OF STROKE-AFFECTED LIMBS. A KEY PROBLEM IN STROKE REHABILITATION THERAPY IS TO HAVE THE STROKE IMPAIRED LIMBS EXERCISED ENOUGH TO AVOID MUSCLE ATROPHY OR DEFORMATION FROM CONTRACTURES. IN GENERAL, PHYSICAL THERAPISTS DO NOT HAVE SUFFICIENT TIME TO WORK WITH THE PATIENT TO PROVIDE THE OPTIMUM RECOVERY RESULT. THE EFFECT OF THIS TO SOCIETY IS 500,000 STROKES PER YEAR WITH $50,000 SPENT ON EACH PATIENT IN AVERAGE STROKE RECOVERY COSTS, LONGRECOVERY TIMES, AND IN MANY CASES, INCOMPLETE RECOVERY. IMPLANTABLE INTELLIGENT ELECTRONIC STIMULATION DEVICES SHOULD SPEED RECOVERY, LOWER PHYSICAL THERAPY COST, AND IMPROVE RECOVERY PROGNOSIS. IN PHASE I, WE WILL EVALUATE THE FEASIBILITY OF DEVELOPING A PRACTICAL DEVICE, WHILE IN PHASE II, WE WOULD BUILD AND TEST A PRE-PRODUCTION PROTOTYPE. THE DEVICE COULD LEAD TO A $250,000,000 MARKET IN SIX YEARS.
Technology keywords
Not reported